Further EBV-derived viral products, i.e., EBV nuclear antigen 2 (EBNA2), EBV-encoded small RNAs (EBERs), and LMP1, contribute to oncogenesis in malignancies, including post-transplant lymphoproliferative disorder (PTLD), Hodgkin lymphoma (HL), diffuse large B cell lymphoma (DL-BCL), and nasopharyngeal carcinoma (NPC) [41,89]. This evidence concerns the gene PDLIM7 and post-transplant lymphoproliferative disease.